EFNB1/B2 dKO mice exhibit lower clinical scores after MOG35–55 induced EAE.
EFNB1/B2 dKO T cells show impaired Th17 differentiation and migration.
EFNB1/B2 are expressed on human Th17 cells in vitro and on T cells in MS lesions.
EFNB1/B2 reverse signaling increases Th17 migration through BBB endothelial cells.